Depakote

Seizure Disorders

Depakote is used to treat several types of epilepsy. It may be used alone or with other medications to control complex partial seizures, which affect a specific part of the brain. It is also used to treat simple and complex absence seizures, which involve brief lapses in consciousness or staring spells.

Bipolar Disorder

This medication is used to treat the manic phase of bipolar disorder. This condition involves periods of extreme mood swings, including episodes of high energy, racing thoughts, or irritability. Depakote helps to manage these symptoms and stabilize mood.

Migraine Prevention

Depakote is used to prevent migraine headaches in adults. It is taken regularly to help reduce how often migraines occur. It is important to note that this medication is not designed to stop a migraine attack that is already in progress.

Mechanism of Action

Depakote belongs to a class of medications known as anticonvulsants. It is thought to work by increasing the concentration of gamma-aminobutyric acid (GABA) in the brain.

GABA is a neurotransmitter that acts as a natural calming agent. It helps block or inhibit certain signals in the central nervous system. By boosting GABA levels, the medication helps reduce the excessive electrical activity in the brain that can lead to seizures.

Effects on Specific Conditions

• Seizures: The medication helps stabilize nerve activity, preventing the abnormal electrical discharges that cause seizures.
• Bipolar Disorder: By calming overactive nerve signals, it helps balance moods and manage the symptoms of manic episodes.
• Migraine Prevention: Although the exact way it prevents migraines is not fully established, it is believed to work by reducing the brain's sensitivity to triggers that cause nerve overstimulation and headache pain.

Common Side Effects

Many people using Depakote experience mild side effects. These often improve as the body adjusts to the medication. Common symptoms include:

• Nausea, vomiting, or stomach pain
• Diarrhea or constipation
• Changes in appetite and weight gain
• Drowsiness, dizziness, or weakness
• Headache
• Tremors or shaking
• Blurred or double vision
• Temporary hair loss
• Unusual taste in the mouth

Serious Side Effects

Some side effects require immediate medical attention. Contact a healthcare provider right away if you experience:

• Signs of liver problems, such as yellowing of the skin or eyes (jaundice), dark urine, or swelling in the face
• Severe pain in the upper stomach that spreads to the back, which may indicate pancreatitis
• Unusual bruising or bleeding
• Confusion, extreme tiredness, or vomiting, which may be signs of high ammonia levels in the blood
• A significant drop in body temperature (hypothermia)
• Severe skin reactions, including a rash, blisters, or peeling skin

Mood and Mental Health

Depakote may cause changes in mood or behavior. It is important to monitor for new or worsening depression, anxiety, agitation, or suicidal thoughts and actions. If these changes occur, contact a healthcare professional immediately.

Boxed Warnings

Depakote has several boxed warnings, which are the most serious warnings issued by the FDA. These include:

• Liver Damage: Severe or fatal liver failure can occur, particularly during the first six months of treatment. Children under the age of two and people with certain genetic conditions are at the highest risk.
• Pancreatitis: Life-threatening inflammation of the pancreas can happen at any time during treatment. Symptoms may include severe abdominal pain, nausea, and vomiting.
• Birth Defects: This medication can cause serious birth defects, such as neural tube defects, and may affect the brain development and IQ of children exposed during pregnancy.

Pregnancy and Reproduction

Depakote is contraindicated for the prevention of migraine headaches in pregnant women. For conditions like epilepsy or bipolar disorder, it is generally only used during pregnancy if other treatments have failed to control symptoms. People of childbearing age should use effective birth control while taking this medication and consult with a healthcare provider if they plan to become pregnant.

Mental Health and Suicidal Thoughts

Like many medications used to treat seizures, Depakote may increase the risk of suicidal thoughts or behaviors. It is important to monitor for new or worsening depression, anxiety, agitation, or any unusual changes in mood or behavior.

Other Serious Precautions

• Blood Disorders: This medication can lower platelet counts in the blood, which may increase the risk of bruising or bleeding. Regular blood tests are often required to monitor these levels.
• High Ammonia Levels: Depakote can cause high levels of ammonia in the blood (hyperammonemia), which can lead to confusion, lack of energy, or vomiting. This risk may increase if Depakote is taken with certain other medications, such as topiramate.
• Mitochondrial Disorders: People with certain genetic mitochondrial disorders, such as Alpers-Huttenlocher syndrome, are at a significantly higher risk for acute liver failure and death when taking this medication.
• Drug Interactions: Depakote interacts with many other medications, which can change how those drugs work or increase the risk of side effects.

Pregnancy Risks

Depakote can cause serious harm to an unborn baby if taken during pregnancy. Research shows that children exposed to this medication in the womb have a higher risk of major birth defects, such as neural tube defects like spina bifida, heart defects, and limb malformations. These defects often occur in the first month of pregnancy, sometimes before a person knows they are pregnant.

In addition to physical birth defects, exposure to Depakote during pregnancy is linked to lower IQ scores and developmental problems in children as they grow. These issues may include delays in walking and talking, as well as an increased risk of autism spectrum disorders.

For individuals using Depakote to prevent migraine headaches, the medication is generally not recommended during pregnancy. For those treating epilepsy or bipolar disorder, healthcare providers usually only prescribe Depakote if other medications have failed to control symptoms. Effective birth control is typically recommended for anyone of childbearing age taking this drug.

Breastfeeding Considerations

Depakote passes into breast milk in small amounts. While many healthcare providers consider breastfeeding while taking Depakote to be acceptable, it is important to monitor the nursing infant for potential side effects. Watch for signs such as unusual bruising, bleeding, or yellowing of the skin or eyes. Always consult with a healthcare professional to weigh the benefits of breastfeeding against potential risks to the infant.

Oral Formulations

Depakote is provided in different oral formats designed to release the medication into the body in specific ways:

• Delayed-Release Tablets: These tablets are formulated to resist dissolving in the stomach, instead releasing the medication once they reach the small intestine. This design is intended to help reduce potential stomach upset.
• Extended-Release Tablets: These tablets release the medication gradually over a longer period. Because the medication is released slowly, this form is typically taken less frequently than the delayed-release version.
• Sprinkle Capsules: These capsules contain specially coated particles of the medication. They can be swallowed whole, or for patients who have difficulty swallowing tablets or capsules, they can be opened and the contents sprinkled onto a small amount of soft food, such as applesauce or pudding.

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) has approved Depakote (divalproex sodium) for the following uses:

• Seizure Disorders: It is approved for use alone or with other medications to treat complex partial seizures and simple or complex absence seizures.
• Bipolar Disorder: It is indicated for the treatment of manic episodes associated with bipolar disorder.
• Migraine Prevention: It is approved to help prevent migraine headaches, though it is not used to treat a migraine that has already begun.

Boxed Warnings

Depakote carries several boxed warnings, which are the FDA's most serious safety alerts. These include:

• Hepatotoxicity: Severe or fatal liver failure has occurred, usually within the first six months of treatment. Children under two years of age and individuals with certain hereditary mitochondrial disorders are at a significantly higher risk.
• Fetal Risk: Exposure to this medication during pregnancy can cause serious birth defects, such as neural tube defects, and may lead to decreased IQ and developmental issues in the child. Because of these risks, it is generally not recommended for migraine prevention in pregnant women.
• Pancreatitis: Cases of life-threatening inflammation of the pancreas have been reported in both children and adults. This can occur shortly after starting the drug or after several years of use.

Other Regulatory Safety Information

The FDA requires a general warning for all antiepileptic drugs, including Depakote, regarding the increased risk of suicidal thoughts or behavior. Patients and caregivers are advised to monitor for any changes in mood, symptoms of depression, or unusual behavior. Additionally, the FDA has issued communications regarding the specific risks of decreased IQ in children whose mothers took the medication while pregnant.

Risks of Abrupt Discontinuation

You should not stop taking Depakote without first consulting your healthcare provider, even if you feel better or experience side effects. Stopping the medication suddenly can cause a severe, long-lasting, and potentially life-threatening type of seizure. For individuals taking the medication for mood disorders, stopping abruptly may also cause symptoms to return or worsen.

The Tapering Process

To safely discontinue Depakote, a doctor will usually provide a schedule to gradually reduce the dose over a period of time. This tapering process is designed to minimize the risk of withdrawal symptoms and seizure activity. During this time, it is important to follow the instructions exactly and report any new or worsening symptoms to your medical team.

• Do not skip doses or stop treatment early without medical advice.
• If you miss a dose, follow your doctor's instructions or contact them for guidance rather than stopping the medication.